Placeholder Content Image

WHO sounds new warning against use of ibuprofen for coronavirus symptoms

<div class="post_body_wrapper"> <div class="post_body"> <div class="body_text "> <p>The World Health Organisation has recommended that people suffering from COVID-19 symptoms to avoid taking ibuprofen after French officials warned that anti-inflammatory drugs could worsen the effects of the virus.</p> <p>The warning came after French Health Minister Olivier Veran followed a recent study in The Lancet medical journal that hypothesised that an enzyme boosted by anti-inflammatory drugs such as ibuprofen could worsen COVID-19 infections.</p> <p>When asked about the study, WHO spokesman Christian Lindmeier told reporters in Geneva that the UN health agency’s experts were “looking into this to give further guidance”.</p> <p>"In the meantime, we recommend using rather paracetamol, and do not use ibuprofen as a self-medication. That's important," he said.</p> <p>He added that if ibuprofen had been "prescribed by the healthcare professionals, then, of course, that's up to them."</p> <p>Mr Lindmeier’s comments came after Veran made a tweet cautioning the use of ibuprofen and other anti-inflammatory drugs.</p> <p>"In the case of fever, take paracetamol," he wrote.</p> <p>A spokesperson for British pharmaceutical company Reckitt Benckiser, which makes Nurofen, said in an email statement that the company is aware of concerns about the use of steroids for the alleviation of COVID-19 symptoms.</p> <p>“Consumer safety is our number one priority," the spokesperson said, stressing that "Ibuprofen is a well-established medicine that has been used safely as a self-care fever and pain reducer, including in viral illnesses, for more than 30 years."</p> <p>"We do not currently believe there is any proven scientific evidence linking over-the-counter use of ibuprofen to the aggravation of COVID-19," the statement said.</p> <p>The COVID-19 pandemic has currently infected 190,000 people worldwide and killed more than 7,800. It causes mild symptoms in most people, but can result in pneumonia and in some cases, severe illness that can lead to multiple organ failure.</p> </div> </div> </div>

News

Placeholder Content Image

Nurofen settles for $3.5 million after misleading consumers over pain relief

<p>The manufacturers of pain relief drug Nurofen will pay $3.5 million compensation to consumers after a class action against their “misleading” Specific Pain Range packaging.</p> <p>The company said in a statement it had made an offer to settle.</p> <p>“Nurofen has offered to settle the Specific Pain Range class action in Australia to ensure that consumers who may have been misled are appropriately and swiftly compensated,” a spokeswoman said.</p> <p>“It was never our intention to mislead, but we recognise that we could have done more to assist our consumers in navigating the Nurofen Specific Pain Range in Australia.”</p> <p>“We have taken the Nurofen Specific Pain Range cases seriously, and have taken steps to ensure that future marketing campaigns are sensitive to the risk of misinterpretation and confusion, while providing consumers with an informed choice.”</p> <p>Law firm Bannister Law, which brought the class action, said Nurofen maker Reckitt Benckiser Australia had agreed to a settlement of $3.5 million. The money will go into a fund to be administered by an independent third party, and distributed eligible group members.</p> <p>“We anticipate Settlement Notices will soon be published in newspapers in every Australian state, calling for consumers who purchased the Nurofen Specific Pain Range products between 1 January 2011 and 31 December 2015 to come forward and register their claim for compensation from the settlement fund,” the law firm said in a statement.</p> <p>The original class action was brought against Reckitt Benckiser for misleading and deceiving customers by claiming the “Specific Pain Range” was specially formulated to treat separate ailments.</p> <p>“However, each product contained the same active ingredient and could not specifically treat one pain as opposed to another,” the claim said.</p> <p>Bannister Law’s founder and Principal Charles Bannister said the advertising “exploited” customers who were “duped” into paying more for basic products.</p> <p>“None of these costly tablets actually targeted these specific pain symptoms. Australians have a right to feel duped by the deceptive marketing and selling of these expensive pain tablets which were sold at a premium price,” he said.</p> <p> </p>

Legal

Placeholder Content Image

Ibuprofen linked to 30% increased risk of cardiac arrest

<p>A 10-year Danish study of almost 30,000 participants has discovered a link between the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Neurofen) and a 31 per cent increase in the risk of cardiac arrest.</p> <p>Researchers from Copenhagen University Hospital Gentofte are calling for tighter restrictions to be placed on the sale of these drugs. “Allowing these drugs to be purchased without a prescription, and without any advice or restrictions, sends a message to the public that they must be safe,” said lead author and professor of cardiology Gunnar Gislason.</p> <p>Among other NSAIDs studied were diclofenac (the second-most commonly used NSAID, associated with a whopping 51 per cent increased risk), rofecoxib and celecoxib. It’s believed these drugs may cause arteries to constrict, restricting blood flow to the heart, blood blots and a rise in blood pressure.</p> <p>Professor Garry Jennings, Chief Medical Officer at the Australian Heart Foundation told AAP the findings are concerning, but consumers should not panic. “In absolute terms this is a relatively small risk but it seems to be fairly real,” he said. “There is really no information which suggests that they can cause either a cardiac arrest or heart attack out of the blue. I think that is very unlikely.”</p> <p>Professor Jennings says those who are most at risk are people who have not yet discovered they are suffering from a heart condition. The call for ibuprofen restrictions comes just months after the Therapeutic Goods Administration ruled that, from 2018, painkillers containing codeine would require a prescription.</p> <p>“There is an assumption that if you can buy something anywhere, then they must be safe and we know these drugs are not safe, this is not the only problem associated with them,” he added, explaining overuse of NSAIDs is also known to cause stomach ulcers and liver and kidney issues.</p>

News

Our Partners